101 related articles for article (PubMed ID: 21382861)
21. Cerebrospinal fluid levels of soluble amyloid precursor protein and β-amyloid 42 in patients with multiple sclerosis, neuromyelitis optica and clinically isolated syndrome.
Mai W; Hu X; Lu Z; Peng F; Wang Y
J Int Med Res; 2011; 39(6):2402-13. PubMed ID: 22289560
[TBL] [Abstract][Full Text] [Related]
22. [Neurofilament protein light in multiple sclerosis].
Zhang Y; Li X; Qiao J
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
[TBL] [Abstract][Full Text] [Related]
23. Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
Lee J; McKinney KQ; Pavlopoulos AJ; Han MH; Kim SH; Kim HJ; Hwang S
Clin Chim Acta; 2016 Nov; 462():118-126. PubMed ID: 27609124
[TBL] [Abstract][Full Text] [Related]
24. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
[TBL] [Abstract][Full Text] [Related]
25. Neuromyelitis optica.
Feingold RM
J Insur Med; 2008; 40(2):136-40. PubMed ID: 19119594
[TBL] [Abstract][Full Text] [Related]
26. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
Saikali P; Cayrol R; Vincent T
Autoimmun Rev; 2009 Dec; 9(2):132-5. PubMed ID: 19389490
[TBL] [Abstract][Full Text] [Related]
27. [Neuromyelitis optica (Devic's disease): a severe variant of multiple sclerosis].
Neuteboom RF; Garssen MP; Hintzen RQ
Ned Tijdschr Geneeskd; 2004 May; 148(22):1097-102. PubMed ID: 15198064
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.
Wang KC; Tsai CP; Lee CL; Chen SY; Chen SJ
Eur Neurol; 2011; 65(2):99-104. PubMed ID: 21273778
[TBL] [Abstract][Full Text] [Related]
29. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
[TBL] [Abstract][Full Text] [Related]
30. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis.
Layh-Schmitt G; Bendl C; Hildt U; Dong-Si T; Jüttler E; Schnitzler P; Grond-Ginsbach C; Grau AJ
Ann Neurol; 2000 May; 47(5):652-5. PubMed ID: 10805338
[TBL] [Abstract][Full Text] [Related]
31. Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders.
Dujmovic I; Mader S; Schanda K; Deisenhammer F; Stojsavljevic N; Kostic J; Berger T; Drulovic J; Reindl M
J Neuroimmunol; 2011 May; 234(1-2):124-30. PubMed ID: 21316112
[TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab.
Pellkofer HL; Krumbholz M; Berthele A; Hemmer B; Gerdes LA; Havla J; Bittner R; Canis M; Meinl E; Hohlfeld R; Kuempfel T
Neurology; 2011 Apr; 76(15):1310-5. PubMed ID: 21482945
[TBL] [Abstract][Full Text] [Related]
33. Devic's neuromyelitis optica: clinical and imaging findings.
Vandevyver V; Lemmerling M; De Potter R; Verstraete K
JBR-BTR; 2007; 90(4):284-7. PubMed ID: 17966247
[TBL] [Abstract][Full Text] [Related]
34. Expanding the spectrum of neuromyelitis optica: friend or foe?
Behbehani R
Curr Opin Ophthalmol; 2007 Nov; 18(6):459-62. PubMed ID: 18162996
[TBL] [Abstract][Full Text] [Related]
35. Is neuromyelitis optica distinct from multiple sclerosis?: something for "lumpers" and "splitters".
Frohman EM; Kerr D
Arch Neurol; 2007 Jun; 64(6):903-5. PubMed ID: 17562944
[No Abstract] [Full Text] [Related]
36. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica.
Ito S; Mori M; Makino T; Hayakawa S; Kuwabara S
Ann Neurol; 2009 Sep; 66(3):425-8. PubMed ID: 19798642
[TBL] [Abstract][Full Text] [Related]
37. Alteration of cystatin C in the cerebrospinal fluid of multiple sclerosis.
Nakashima I; Fujinoki M; Fujihara K; Kawamura T; Nishimura T; Nakamura M; Itoyama Y
Ann Neurol; 2007 Aug; 62(2):197-200; discussion 205. PubMed ID: 16958112
[TBL] [Abstract][Full Text] [Related]
38. [Demyelinating diseases and the cerebrospinal fluid cytoproteinogram].
Limongi JC; Machado LR; Spina-França A
Arq Neuropsiquiatr; 1981 Sep; 39(3):296-300. PubMed ID: 6119970
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid proteomics: a new window for understanding human demyelinating disorders?
Bennett JL; Owens GP
Ann Neurol; 2012 May; 71(5):587-8. PubMed ID: 22522475
[No Abstract] [Full Text] [Related]
40. IFNβ-1b may severely exacerbate Japanese opticspinal MS in neuromyelitis optica spectrum: Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment?
Bomprezzi R; Powers JM; Shimizu J; Tsuji S; Weinshenker BG; Wingerchuk DM
Neurology; 2011 Jul; 77(2):195; discussion 195-6. PubMed ID: 21747078
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
